UNUM THERAPEUTICS CORPORATE PRESENTATION AUGUST 2019 FORWARD-LOOKING STATEMENTS AND RISK FACTORS This presentation and the accompanying oral commentary contain forward-looking statements that involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward looking statements. All statements other than statements of historical fact could be deemed forward-looking, ...

Unum Therapeutics Inc. (UMRX) Q2 2019 Earnings Conference Call August 12, 2019 4:30 PM ET Corporate Participants Chuck Wilson - Chief Executive Officer Jessica Sachs - Chief Medical Officer Seth Ettenberg - Chief Scientific Officer Matt Osborne - Chief Financial Officer Conference Call Participants Vikram Purohit - Morgan Stanley Peter Lawson - SunTrust Robinson Leo Li - Cowen Operator Good afternoon, and welcome to the Unum Therapeutics' Quarterly Investor Conference Call. Today, we will be showing update ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | |------------------------------------------------------------------------------------------------------------------------------|-------------------------------------------- ...

Unum Therapeutics Inc. (UMRX) Q1 2019 Results Earnings Conference Call May 13, 2019 8:00 AM ET Company Participants Stephanie Ascher - Investor Relations Chuck Wilson - Chief Executive Officer John Green - Vice President of Finance Michael Vasconcelles - Chief Medical Officer Seth Ettenberg - Chief Scientific Officer Conference Call Participants Peter Lawson - SunTrust Yaron Werber - Cowen Operator Good day, ladies and gentlemen, and welcome to the Unum Therapeutics' First Quarter 2019 Results Conference Ca ...

Table of Contents Emerging growth company ☒ UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2019 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-38443 UNUM THERAPEUTICS INC. (Exact name of registrant as specified in its charter) D ...

Unum Therapeutics Inc. (UMRX) Q4 2018 Results Earnings Conference Call March 28, 2019 8:00 AM ET Company Participants Stephanie Ascher - Investor Relations Chuck Wilson - Chief Executive Officer John Green - Vice President of Finance Michael Vasconcelles - Chief Medical Officer Seth Ettenberg - Chief Scientific Officer Conference Call Participants Peter Lawson - SunTrust Robinson Humphrey David Nierengarten - Wedbush Securities Operator Good day, ladies and gentlemen, and welcome to the Unum Therapeutics' F ...

Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | --- | --- | --- | --- | |-----------------------------------------------------------------------------|----------------------------------------------------------------------- ...

UNUM THERAPEUTICS CORPORATE PRESENTATION MARCH 2019 FORWARD-LOOKING STATEMENTS AND RISK FACTORS This presentation and the accompanying oral commentary contain forward-looking statements that involve risks, uncertainties and assumptions. If the risks or uncertainties ever materialize or the assumptions prove incorrect, our results may differ materially from those expressed or implied by such forward looking statements. All statements other than statements of historical fact could be deemed forward-looking, i ...